RT Journal Article
SR Electronic
T1 International Olympic Committee (IOC) consensus statement on acute respiratory illness in athletes part 2: non-infective acute respiratory illness
JF British Journal of Sports Medicine
JO Br J Sports Med
FD BMJ Publishing Group Ltd and British Association of Sport and Exercise Medicine
SP 1089
OP 1103
DO 10.1136/bjsports-2022-105567
VO 56
IS 19
A1 Schwellnus, Martin
A1 Adami, Paolo Emilio
A1 Bougault, Valerie
A1 Budgett, Richard
A1 Clemm, Hege Havstad
A1 Derman, Wayne
A1 Erdener, Uğur
A1 Fitch, Ken
A1 Hull, James H
A1 McIntosh, Cameron
A1 Meyer, Tim
A1 Pedersen, Lars
A1 Pyne, David B
A1 Reier-Nilsen, Tonje
A1 Schobersberger, Wolfgang
A1 Schumacher, Yorck Olaf
A1 Sewry, Nicola
A1 Soligard, Torbjørn
A1 Valtonen, Maarit
A1 Webborn, Nick
A1 Engebretsen, Lars
YR 2022
UL http://bjsm.bmj.com/content/56/19/1089.abstract
AB Acute respiratory illness (ARill) is common and threatens the health of athletes. ARill in athletes forms a significant component of the work of Sport and Exercise Medicine (SEM) clinicians. The aim of this consensus is to provide the SEM clinician with an overview and practical clinical approach to non-infective ARill in athletes. The International Olympic Committee (IOC) Medical and Scientific Committee appointed an international consensus group to review ARill in athletes. Key areas of ARill in athletes were originally identified and six subgroups of the IOC Consensus group established to review the following aspects: (1) epidemiology/risk factors for ARill, (2) infective ARill, (3) non-infective ARill, (4) acute asthma/exercise-induced bronchoconstriction and related conditions, (5) effects of ARill on exercise/sports performance, medical complications/return-to-sport (RTS) and (6) acute nasal/laryngeal obstruction presenting as ARill. Following several reviews conducted by subgroups, the sections of the consensus documents were allocated to ‘core’ members for drafting and internal review. An advanced draft of the consensus document was discussed during a meeting of the main consensus core group, and final edits were completed prior to submission of the manuscript. This document (part 2) of this consensus focuses on respiratory conditions causing non-infective ARill in athletes. These include non-inflammatory obstructive nasal, laryngeal, tracheal or bronchial conditions or non-infective inflammatory conditions of the respiratory epithelium that affect the upper and/or lower airways, frequently as a continuum. The following aspects of more common as well as lesser-known non-infective ARill in athletes are reviewed: epidemiology, risk factors, pathology/pathophysiology, clinical presentation and diagnosis, management, prevention, medical considerations and risks of illness during exercise, effects of illness on exercise/sports performance and RTS guidelines.